

We designed a synthetic DNA origami needle‐like structure inspired by bacteriophages for targeted drug delivery. Functionalized with trastuzumab antibodies, cholesterol, and dyes, it selectively targets SKBR3 cancer cells. A glutathione‐triggered dye payload enables controlled release, and delivery is verified using confocal microscopy and live cell tracking, confirming successful cytosolic delivery. ABSTRACT Inspired by the natural ability of bacteriophages to deliver genetic material directly into host cells, we employed a bottom‐up approach to construct a multifunctional synthetic DNA origami needle‐like structure. This origami is functionalized with trastuzumab antibodies, cholesterol, protective polymers, and two dyes, which together enable selective targeting and insertion into SKBR3 cancer cells. A disulfide‐linked dye payload was attached to the apex of the needle, allowing controlled release in the cytoplasm triggered by the high intracellular glutathione concentration. Real‐time tracking of the payload confirmed both successful targeting of the origami structure and subsequent direct cytosolic delivery. By mimicking fundamental mechanisms of bacteriophages, we propose that this artificial needle structure can serve as a prototypical device for the targeted delivery of small‐molecule drugs directly into the cytosol. We designed a synthetic DNA origami needle-like structure inspired by bacteriophages for targeted drug delivery. Functionalized with trastuzumab antibodies, cholesterol, and dyes, it selectively targets SKBR3 cancer cells. A glutathione-triggered dye payload enables controlled release, and delivery is verified using confocal microscopy and live cell tracking, confirming successful cytosolic delivery. ABSTRACT Inspired by the natural ability of bacteriophages to deliver genetic material directly into host cells, we employed a bottom-up approach to construct a multifunctional synthetic DNA origami needle-like structure. This origami is functionalized with trastuzumab antibodies, cholesterol, protective polymers, and two dyes, which together enable selective targeting and insertion into SKBR3 cancer cells. A disulfide-linked dye payload was attached to the apex of the needle, allowing controlled release in the cytoplasm triggered by the high intracellular glutathione concentration. Real-time tracking of the payload confirmed both successful targeting of the origami structure and subsequent direct cytosolic delivery. By mimicking fundamental mechanisms of bacteriophages, we propose that this artificial needle structure can serve as a prototypical device for the targeted delivery of small-molecule drugs directly into the cytosol. Advanced Science, EarlyView.
Medical Journal
|2nd Apr, 2026
|Diabetes Journals
Medical Journal
|2nd Apr, 2026
|Diabetes Journals
Medical Journal
|2nd Apr, 2026
|Diabetes Journals
Medical Journal
|2nd Apr, 2026
|Diabetes Journals
Medical Journal
|1st Apr, 2026
|Diabetes Journals
Medical Journal
|2nd Apr, 2026
|Oxford University Press
Medical Journal
|2nd Apr, 2026
|Oxford University Press